论文部分内容阅读
目的 探讨临床收治的冠心病心绞痛患者应用辛伐他汀与低分子肝素钙联合方案治疗的效果.方法 选择冠心病心绞痛100例,均为南乐县中兴医院心血管科2015年4月至2016年4月收治,在常规抗冠心病心绞痛药物应用基础上,随机分组,就单用辛伐他汀治疗(对照组,n=50)与辛伐他汀与低分子肝素钙联合治疗(观察组,n=50)效果展开对比.结果 两组治疗前ST段下移情况、心绞痛持续时间及发作次数均无差异(P＞0.05).治疗后ST段下移均有程度不等减轻,心绞痛持续时间及发作次数均有程度不等减少,但观察组较对照组更为显著(P＜0.05).观察组临床总有效率和心电图改善总有效率均明显高于对照组(94％ vs 72％;92％ vs74％).结论 冠心病心绞痛患者采用辛伐他汀与低分子肝素钙联合方案治疗,可增强临床效果,改善心绞痛症状,对保障患者预后具非常重要的意义,值得临床广泛推广应用.“,”Objective To explore tihe cliuical efficacy of simvastatin combing with low-molecular-weight heparin calcium on angina pectoris.Methods A total of 100 cases of angina pectoris that admitted to our hospital during April,2015 and April,2016 were randomly divided into observation group (n =50) and control group (n =30).Both groups were treated with conventional therapy,But the observation group was also given extra simvastatin combing with low-molecular-weight heparin calcium.Results The differences were not statistically significant on ST segment down situation,the duration and times of angina pectoris between two groups before treatment (P ＞ 0.05).After treatment,ST segment down situation,the duration and times of angina pectoris were reduced during two groups,but the observation group were more serious(P ＜ 0.05).Total effective rate of clinical effect and ECG improve were higher in the observation group than in the control group(94％ vs 72％;92％ vs 74％).Conclusion Simvastatin combing with Low-molecular-weight heparin calcium can improve clinical effective and change the symptoms of angina pectoris and should be applied in clinic in large scale.